TACTICATH ABLATION CATHETER, SENSOR ENABLED
Device
Abbott Laboratories
Total Payments
$1.1M
Transactions
3,433
Doctors
1,219
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $917,610 | 2,025 | 787 |
| 2023 | $193,046 | 1,408 | 700 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $469,104 | 246 | 42.2% |
| Consulting Fee | $248,071 | 65 | 22.3% |
| Travel and Lodging | $130,568 | 455 | 11.8% |
| Grant | $125,183 | 26 | 11.3% |
| Food and Beverage | $124,183 | 2,625 | 11.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $11,000 | 13 | 1.0% |
| Space rental or facility fees (teaching hospital only) | $2,500 | 1 | 0.2% |
| Education | $45.74 | 2 | 0.0% |
Payments by Type
General
$641,551
3,187 transactions
Research
$469,104
246 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Abbott Atrial Fibrillation Post Approval Study | Abbott Laboratories | $144,521 | 0 |
| Safety and Effectiveness of the TactiFlex(TM) Ablation Catheter, Sensor Enabled(TM) (TactiFlex SE) for Treating Drug-refractory, Symptomatic Atrial Fibrillation | Abbott Laboratories | $105,418 | 0 |
| A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects with PAF: (FlexPulse IDE) | Abbott Laboratories | $98,772 | 0 |
| Abbott AF Post Approval Study | Abbott Laboratories | $64,891 | 0 |
| FlexPulse IDE | Abbott Laboratories | $37,870 | 0 |
| Safety and Effectiveness of the TactiFlexTM Ablation Catheter, Sensor EnabledTM (TactiFlex SE) for Treating Drug-refractory, Symptomatic Atrial Fibrillation. | Abbott Laboratories | $17,633 | 0 |
Top Doctors Receiving Payments for TACTICATH ABLATION CATHETER, SENSOR ENABLED
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Loma Linda, CA | $471,666 | 250 |
| , MD PHD | Internal Medicine | Boston, MA | $41,754 | 37 |
| , M.D | Internal Medicine | Westminster, CA | $29,913 | 5 |
| , MD | Cardiovascular Disease | Winter Park, FL | $17,835 | 21 |
| , M.D | Cardiovascular Disease | New Haven, CT | $16,942 | 8 |
| , M.D., M.H.S | Cardiovascular Disease | Durham, NC | $16,507 | 15 |
| , M.D | Family Medicine | Stockton, CA | $16,356 | 23 |
| , MD | Clinical Cardiac Electrophysiology | Ann Arbor, MI | $15,165 | 1 |
| , MD | Cardiovascular Disease | San Diego, CA | $14,349 | 3 |
| , MD | Clinical Cardiac Electrophysiology | Salt Lake City, UT | $13,322 | 3 |
| , MD | Clinical Cardiac Electrophysiology | Cleveland, OH | $11,711 | 4 |
| Takahiro Tsushima | Student in an Organized Health Care Education/Training Program | Cleveland, OH | $11,250 | 1 |
| , M.D., M.A | Cardiovascular Disease | Overland Park, KS | $9,955 | 16 |
| , MD | Clinical Cardiac Electrophysiology | Philadelphia, PA | $9,918 | 13 |
| , M.D | Clinical Cardiac Electrophysiology | Littleton, CO | $8,940 | 10 |
| , M.D | Cardiovascular Disease | New York, NY | $8,654 | 26 |
| , PA-C | Physician Assistant | Lewistown, PA | $8,642 | 1 |
| , MD | Student in an Organized Health Care Education/Training Program | Plano, TX | $7,678 | 2 |
| , M.D | Clinical Cardiac Electrophysiology | Indianapolis, IN | $7,500 | 1 |
| , M.D | Student in an Organized Health Care Education/Training Program | Chicago, IL | $7,500 | 1 |
| , MD | Student in an Organized Health Care Education/Training Program | Brooklyn, NY | $7,500 | 1 |
| , M.D | Cardiovascular Disease | Cleveland, OH | $7,500 | 1 |
| , MD | Internal Medicine | Riverview, FL | $6,945 | 1 |
| Nicholas Beccarino | Cardiovascular Disease | New York, NY | $6,819 | 1 |
| Hugh Mcelderry | Clinical Cardiac Electrophysiology | Birmingham, AL | $6,782 | 5 |
Ad
Manufacturing Companies
- Abbott Laboratories $1.1M
Product Information
- Type Device
- Total Payments $1.1M
- Total Doctors 1,219
- Transactions 3,433
About TACTICATH ABLATION CATHETER, SENSOR ENABLED
TACTICATH ABLATION CATHETER, SENSOR ENABLED is a device associated with $1.1M in payments to 1,219 healthcare providers, recorded across 3,433 transactions in the CMS Open Payments database. The primary manufacturer is Abbott Laboratories.
Payment data is available from 2023 to 2024. In 2024, $917,610 was paid across 2,025 transactions to 787 doctors.
The most common payment nature for TACTICATH ABLATION CATHETER, SENSOR ENABLED is "Unspecified" ($469,104, 42.2% of total).
TACTICATH ABLATION CATHETER, SENSOR ENABLED is associated with 6 research studies, including "Abbott Atrial Fibrillation Post Approval Study" ($144,521).